Incretin effect due to increased secretion and decreased clearance of insulin in normal humans

L. T. Shuster, V. L W Go, R. A. Rizza, P. C. O'Brien, F. J. Service

Research output: Contribution to journalArticle

86 Citations (Scopus)

Abstract

To assess the contribution of changes in insulin secretion and clearance to the incretin effect (greater insulinemia after oral than after intravenous glucose), 10 healthy subjects were studied after oral glucose (1 g/kg body wt) and again when glucose was infused intravenously at rates to match arterialized plasma glucose concentrations after oral glucose. Although basal and integrated plasma glucose did not differ between oral and intravenous glucose, integrated responses of insulin (3.3 ± 0.5 vs. 1.8 ± 0.4 mU·ml-1·240 min-1, P<.001), C-peptide (456.5 ± 58.5 vs. 327.9 ± 46.3 ng·ml-1·240 min-1, P = .002), gastric inhibitory polypeptide, (16.8 ± 3.5 vs. -2.8 ± 1.0 μg·ml-1·240 min-1, P<.001), and insulin secretion (6.6 ± 1.1 vs 4.7 ± 0.7 U·240 min-1, P = .003) were greater with oral than intravenous glucose. However, insulin clearance, whether calculated as the molar ratio of integrated C-peptide to integrated insulin responses (6.9 ± 0.7 vs. 14.2 ± 3.8, P = .005) or from the formula insulin clearance equals insulin secretion divided by integrated insulin responses (1.1 ± 0.2 vs. 2.5 ± 0.7 L·m-2, respectively, P = .002), was less for oral than for intravenous glucose. Therefore, the incretin effect is mediated both by increased secretion and decreased clearance of insulin.

Original languageEnglish (US)
Pages (from-to)200-203
Number of pages4
JournalDiabetes
Volume37
Issue number2
StatePublished - 1988

Fingerprint

Incretins
Insulin
Glucose
C-Peptide
Gastric Inhibitory Polypeptide
Healthy Volunteers

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Internal Medicine

Cite this

Shuster, L. T., Go, V. L. W., Rizza, R. A., O'Brien, P. C., & Service, F. J. (1988). Incretin effect due to increased secretion and decreased clearance of insulin in normal humans. Diabetes, 37(2), 200-203.

Incretin effect due to increased secretion and decreased clearance of insulin in normal humans. / Shuster, L. T.; Go, V. L W; Rizza, R. A.; O'Brien, P. C.; Service, F. J.

In: Diabetes, Vol. 37, No. 2, 1988, p. 200-203.

Research output: Contribution to journalArticle

Shuster, LT, Go, VLW, Rizza, RA, O'Brien, PC & Service, FJ 1988, 'Incretin effect due to increased secretion and decreased clearance of insulin in normal humans', Diabetes, vol. 37, no. 2, pp. 200-203.
Shuster LT, Go VLW, Rizza RA, O'Brien PC, Service FJ. Incretin effect due to increased secretion and decreased clearance of insulin in normal humans. Diabetes. 1988;37(2):200-203.
Shuster, L. T. ; Go, V. L W ; Rizza, R. A. ; O'Brien, P. C. ; Service, F. J. / Incretin effect due to increased secretion and decreased clearance of insulin in normal humans. In: Diabetes. 1988 ; Vol. 37, No. 2. pp. 200-203.
@article{0c42e5c5ffd74c16aa304ade54cce5c3,
title = "Incretin effect due to increased secretion and decreased clearance of insulin in normal humans",
abstract = "To assess the contribution of changes in insulin secretion and clearance to the incretin effect (greater insulinemia after oral than after intravenous glucose), 10 healthy subjects were studied after oral glucose (1 g/kg body wt) and again when glucose was infused intravenously at rates to match arterialized plasma glucose concentrations after oral glucose. Although basal and integrated plasma glucose did not differ between oral and intravenous glucose, integrated responses of insulin (3.3 ± 0.5 vs. 1.8 ± 0.4 mU·ml-1·240 min-1, P<.001), C-peptide (456.5 ± 58.5 vs. 327.9 ± 46.3 ng·ml-1·240 min-1, P = .002), gastric inhibitory polypeptide, (16.8 ± 3.5 vs. -2.8 ± 1.0 μg·ml-1·240 min-1, P<.001), and insulin secretion (6.6 ± 1.1 vs 4.7 ± 0.7 U·240 min-1, P = .003) were greater with oral than intravenous glucose. However, insulin clearance, whether calculated as the molar ratio of integrated C-peptide to integrated insulin responses (6.9 ± 0.7 vs. 14.2 ± 3.8, P = .005) or from the formula insulin clearance equals insulin secretion divided by integrated insulin responses (1.1 ± 0.2 vs. 2.5 ± 0.7 L·m-2, respectively, P = .002), was less for oral than for intravenous glucose. Therefore, the incretin effect is mediated both by increased secretion and decreased clearance of insulin.",
author = "Shuster, {L. T.} and Go, {V. L W} and Rizza, {R. A.} and O'Brien, {P. C.} and Service, {F. J.}",
year = "1988",
language = "English (US)",
volume = "37",
pages = "200--203",
journal = "Diabetes",
issn = "0012-1797",
publisher = "American Diabetes Association Inc.",
number = "2",

}

TY - JOUR

T1 - Incretin effect due to increased secretion and decreased clearance of insulin in normal humans

AU - Shuster, L. T.

AU - Go, V. L W

AU - Rizza, R. A.

AU - O'Brien, P. C.

AU - Service, F. J.

PY - 1988

Y1 - 1988

N2 - To assess the contribution of changes in insulin secretion and clearance to the incretin effect (greater insulinemia after oral than after intravenous glucose), 10 healthy subjects were studied after oral glucose (1 g/kg body wt) and again when glucose was infused intravenously at rates to match arterialized plasma glucose concentrations after oral glucose. Although basal and integrated plasma glucose did not differ between oral and intravenous glucose, integrated responses of insulin (3.3 ± 0.5 vs. 1.8 ± 0.4 mU·ml-1·240 min-1, P<.001), C-peptide (456.5 ± 58.5 vs. 327.9 ± 46.3 ng·ml-1·240 min-1, P = .002), gastric inhibitory polypeptide, (16.8 ± 3.5 vs. -2.8 ± 1.0 μg·ml-1·240 min-1, P<.001), and insulin secretion (6.6 ± 1.1 vs 4.7 ± 0.7 U·240 min-1, P = .003) were greater with oral than intravenous glucose. However, insulin clearance, whether calculated as the molar ratio of integrated C-peptide to integrated insulin responses (6.9 ± 0.7 vs. 14.2 ± 3.8, P = .005) or from the formula insulin clearance equals insulin secretion divided by integrated insulin responses (1.1 ± 0.2 vs. 2.5 ± 0.7 L·m-2, respectively, P = .002), was less for oral than for intravenous glucose. Therefore, the incretin effect is mediated both by increased secretion and decreased clearance of insulin.

AB - To assess the contribution of changes in insulin secretion and clearance to the incretin effect (greater insulinemia after oral than after intravenous glucose), 10 healthy subjects were studied after oral glucose (1 g/kg body wt) and again when glucose was infused intravenously at rates to match arterialized plasma glucose concentrations after oral glucose. Although basal and integrated plasma glucose did not differ between oral and intravenous glucose, integrated responses of insulin (3.3 ± 0.5 vs. 1.8 ± 0.4 mU·ml-1·240 min-1, P<.001), C-peptide (456.5 ± 58.5 vs. 327.9 ± 46.3 ng·ml-1·240 min-1, P = .002), gastric inhibitory polypeptide, (16.8 ± 3.5 vs. -2.8 ± 1.0 μg·ml-1·240 min-1, P<.001), and insulin secretion (6.6 ± 1.1 vs 4.7 ± 0.7 U·240 min-1, P = .003) were greater with oral than intravenous glucose. However, insulin clearance, whether calculated as the molar ratio of integrated C-peptide to integrated insulin responses (6.9 ± 0.7 vs. 14.2 ± 3.8, P = .005) or from the formula insulin clearance equals insulin secretion divided by integrated insulin responses (1.1 ± 0.2 vs. 2.5 ± 0.7 L·m-2, respectively, P = .002), was less for oral than for intravenous glucose. Therefore, the incretin effect is mediated both by increased secretion and decreased clearance of insulin.

UR - http://www.scopus.com/inward/record.url?scp=0023836241&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023836241&partnerID=8YFLogxK

M3 - Article

VL - 37

SP - 200

EP - 203

JO - Diabetes

JF - Diabetes

SN - 0012-1797

IS - 2

ER -